Opicapone
RxNorm 2362167
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2362167 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Opicapone.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Opicapone
(Atom ID: 12389422)
PTPrescribable
Designated preferred name (PT):
Opicapone
(Atom ID: 8718797)
FNPrescribable
Full form of descriptor (FN):
Opicapone (substance)
(Atom ID: 8718798)
PTPrescribable
Designated preferred name (PT):
Opicapone-containing product
(Atom ID: 10808328)
FNPrescribable
Full form of descriptor (FN):
Product containing opicapone (medicinal product)
(Atom ID: 10308276)
Patient Education
Opicapone
Opicapone is used along with levodopa and carbidopa (Sinemet, Rytary) to treat the end-of-dose 'wearing-off' symptoms of Parkinson's disease. Opicapone is an inhibitor of catechol-O-methyltransferase (COMT). Opicapone helps the levodopa and carbidopa work better by allowing more of it to reach the brain, where it has its effects.
[Learn More]
* Please review the disclaimer below.